skip to main content

ULT During Acute Flare — SCE Rheumatology MCQ

Instant feedback + full explanation. One question, done properly.

EasyCrystal ArthropathyULT During Acute FlareSCE Rheumatology

A 48-year-old man with tophaceous gout and stage 3 chronic kidney disease has not previously received urate-lowering therapy (ULT). He is currently experiencing an acute gout flare and reports monthly flares over the preceding 6 months. According to NICE NG219, which statement best describes when ULT should be started?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Usually start at least 2–4 weeks after the flare settles; with frequent flares, ULT may be started during a flare.

Option D is correct. NICE recommends normally starting ULT at least 2–4 weeks after a gout flare has settled. However, people with frequent flares may have no practical flare-free interval, so ULT can be initiated during a flare. This patient’s monthly attacks satisfy that exception. Tophi and stage 3 CKD are independent indications to offer ULT, but they do not make initiation during every flare mandatory, excluding A and C. NICE does not impose an absolute prohibition on starting during a flare, excluding B, or require a 6-month delay, excluding D. Flare prophylaxis should be discussed when starting or titrating ULT; if prophylaxis is chosen, NICE recommends offering colchicine, with alternatives when it is unsuitable.

Reference: National Institute for Health and Care Excellence. Gout: diagnosis and management (NG219), recommendations 1.5.4 and 1.5.11–1.5.12. 2022. https://www.nice.org.uk/guidance/ng219/chapter/Recommendations